1. Laping et al (2002) Inhibition of transforming growth factor (TGF)-b1-induced extracellular matrix with a novel inhibitor of the TGF-b type I receptor kinase activity: SB-431542. Mol.Pharmacol. 62 58.
2. Inman et al (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-b superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol.Pharmacol. 62 65.
3. Matsuyama et al (2003) SB-431542 and Gleevec inhibit transforming growth factor-b-induced proliferation of human osteosarcoma cells. Cancer Res. 63 7791.